OBJECTIVE: To investigate the relation between serum high sensitivity (hs) C reactive protein (CRP), proinflammatory cytokine concentrations, proinflammatory to anti-inflammatory cytokine ratios and long-term prognosis in patients with non-ST elevation acute coronary syndrome (NSTEACS). DESIGN: Prospective follow-up study for the first six months and then for the first year after admission to hospital. SETTING: Tertiary referral centre. PATIENTS: 80 patients (60 men, 20 women, mean age 60 (SD 10) years) with NSTEACS and moderate to high TIMI (Thrombolysis In Myocardial Infarction) risk scores. INTERVENTIONS: Blood samples from patients with NSTEACS were obtained at the time of admission. Serum concentrations of hs-CRP, (hs) pro-inflammatory (interleukin (IL) -1beta, IL-6, tumour necrosis factor alpha) and (hs) anti-inflammatory (IL-10) cytokines were analysed and proinflammatory to anti-inflammatory cytokine ratios were calculated by dividing proinflammatory cytokine concentrations by anti-inflammatory cytokine IL-10. MAIN OUTCOME MEASURE: The primary end point of the study was new coronary events (NCE) defined as the combination of cardiac death, non-fatal myocardial infarction and recurrent rest angina that required hospitalisation within 12 months of follow up. RESULTS: During the one-year follow-up period, 23 patients (29%) met the NCE criteria. Concentrations of hs-CRP, IL-1beta and IL-6 and ratios of IL-1beta:IL-10 and IL-6:IL-10 were significantly higher in patients with NCE than in patients without NCE. In the logistic regression analysis, IL-6:IL-10 ratio was the most important predictor for NCE (p = 0.006) with an odds ratio of 2.24 (95% CI 1.26 to 3.97). CONCLUSIONS: Cytokine concentrations and proinflammatory to anti-inflammatory cytokine ratios may be useful markers for predicting vascular risk in patients with NSTEACS.
OBJECTIVE: To investigate the relation between serum high sensitivity (hs) C reactive protein (CRP), proinflammatory cytokine concentrations, proinflammatory to anti-inflammatory cytokine ratios and long-term prognosis in patients with non-ST elevation acute coronary syndrome (NSTEACS). DESIGN: Prospective follow-up study for the first six months and then for the first year after admission to hospital. SETTING: Tertiary referral centre. PATIENTS: 80 patients (60 men, 20 women, mean age 60 (SD 10) years) with NSTEACS and moderate to high TIMI (Thrombolysis In Myocardial Infarction) risk scores. INTERVENTIONS: Blood samples from patients with NSTEACS were obtained at the time of admission. Serum concentrations of hs-CRP, (hs) pro-inflammatory (interleukin (IL) -1beta, IL-6, tumour necrosis factor alpha) and (hs) anti-inflammatory (IL-10) cytokines were analysed and proinflammatory to anti-inflammatory cytokine ratios were calculated by dividing proinflammatory cytokine concentrations by anti-inflammatory cytokine IL-10. MAIN OUTCOME MEASURE: The primary end point of the study was new coronary events (NCE) defined as the combination of cardiac death, non-fatal myocardial infarction and recurrent rest angina that required hospitalisation within 12 months of follow up. RESULTS: During the one-year follow-up period, 23 patients (29%) met the NCE criteria. Concentrations of hs-CRP, IL-1beta and IL-6 and ratios of IL-1beta:IL-10 and IL-6:IL-10 were significantly higher in patients with NCE than in patients without NCE. In the logistic regression analysis, IL-6:IL-10 ratio was the most important predictor for NCE (p = 0.006) with an odds ratio of 2.24 (95% CI 1.26 to 3.97). CONCLUSIONS: Cytokine concentrations and proinflammatory to anti-inflammatory cytokine ratios may be useful markers for predicting vascular risk in patients with NSTEACS.
Authors: E M Antman; M Cohen; P J Bernink; C H McCabe; T Horacek; G Papuchis; B Mautner; R Corbalan; D Radley; E Braunwald Journal: JAMA Date: 2000-08-16 Impact factor: 56.272
Authors: Georgios K Chalikias; Dimitrios N Tziakas; Juan Carlos Kaski; Eleni I Hatzinikolaou; Dimitrios A Stakos; Ioannis K Tentes; Alexandros Kortsaris; Dimitrios I Hatseras Journal: Atherosclerosis Date: 2005-02-26 Impact factor: 5.162
Authors: M Torzewski; C Rist; R F Mortensen; T P Zwaka; M Bienek; J Waltenberger; W Koenig; G Schmitz; V Hombach; J Torzewski Journal: Arterioscler Thromb Vasc Biol Date: 2000-09 Impact factor: 8.311
Authors: Sean van Diepen; Wendimagegn G Alemayehu; Yinggan Zheng; Pierre Theroux; L Kristin Newby; Kenneth W Mahaffey; Christopher B Granger; Paul W Armstrong Journal: J Thromb Thrombolysis Date: 2016-10 Impact factor: 2.300
Authors: Aymen N Naguib; Joseph D Tobias; Mark W Hall; Mary J Cismowski; Yongjie Miao; N'diris Barry; Thomas Preston; Mark Galantowicz; Timothy M Hoffman Journal: Pediatr Crit Care Med Date: 2013-06 Impact factor: 3.624
Authors: Nicolle Ceneri; Lina Zhao; Bryan D Young; Abigail Healy; Suleyman Coskun; Hema Vasavada; Timur O Yarovinsky; Kenneth Ike; Ruggero Pardi; Lingfen Qin; Li Qin; George Tellides; Karen Hirschi; Judith Meadows; Robert Soufer; Hyung J Chun; Mehran M Sadeghi; Jeffrey R Bender; Alan R Morrison Journal: Arterioscler Thromb Vasc Biol Date: 2016-11-10 Impact factor: 8.311
Authors: Barbara J Jefferis; Peter H Whincup; Paul Welsh; S Goya Wannamethee; Ann Rumley; Lucy T Lennon; Andrew G Thomson; Claire Carson; Shah Ebrahim; Gordon D O Lowe Journal: Atherosclerosis Date: 2008-12-06 Impact factor: 5.162